WDR76 and central nervous system cancer: In the 2021 WHO classification of tumors, additional molecular features have been introduced for glioma classification [21]. Therefore, in the near future, the high expression of WDR76 observed in this study may also be incorporated into glioma diagnosis as a standard molecular characteristic for the malignant subtype of LGG with a poor prognosis.